79 results
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
8 Jan 24
Regulation FD Disclosure
10:29am
Material ESG Factors Pricing & Patient Access Product Innovation Patient Safety and Product Quality Ethics & Conduct Long-Term Value Creation Culture
8-K
EX-99.2
uy0c r4d134qrc
26 Oct 23
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
7:44am
DFAN14A
i9pwnq0g
10 Oct 23
Additional proxy materials by non-management
6:48am
DEFA14A
bwfp7
26 Apr 23
Additional proxy soliciting materials
4:38pm
8-K
EX-99.1
hvy1mpyprfb lb
26 Apr 23
Bristol Myers Squibb Announces Leadership Transition Plan
4:35pm
PX14A6G
rvw8fg
5 Apr 22
Letter to shareholders
4:53pm
DEFA14A
008vp9q
19 Apr 21
Additional proxy soliciting materials
7:41am
PX14A6G
u8o rb5syd6liphbnrv
12 Apr 21
Letter to shareholders
5:29pm